AndoSan

DIETARY_SUPPLEMENT3 trials

Sponsors

Ullevaal University Hospital, Oslo University Hospital, University Hospital, Akershus

Conditions

Allergic AsthmaAllergic RhinoconjunctivitisCrohn's DiseaseImmune ToleranceInflammatory Bowel DiseaseUlcerative Colitis

Phase 2

Agaricus Blazei Murill (ABM) in Patients With Inflammatory Bowel Disease (IBD)

CompletedNCT01106742

Ullevaal University HospitalInflammatory Bowel Disease

Start: 2009-03-31End: 2011-07-31Updated: 2011-07-19

Anti-inflammatory Effect of Agaricus Blazei Murill in Inflammatory Bowel Disease (IBD)

CompletedNCT01496053

Oslo University HospitalCrohn's Disease, Inflammatory Bowel Disease, Ulcerative Colitis

Start: 2011-12-31End: 2016-01-31Updated: 2020-10-08

Unknown Phase

Andosan in Allergic and Asthma Patients

CompletedNCT05192720

University Hospital, AkershusAllergic Asthma, Allergic Rhinoconjunctivitis, Immune Tolerance

Start: 2021-08-31End: 2023-02-28Updated: 2024-06-18

Related Papers

Effect of the Medicinal Agaricus blazei Murill-Based Mushroom Extract, AndoSanTM, on Symptoms, Fatigue and Quality of Life in Patients with Crohn's Disease in a Randomized Single-Blinded Placebo Controlled Study.

2016-07-1414 citations

Effect of a Medicinal Agaricus blazei Murill-Based Mushroom Extract, AndoSan™, on Symptoms, Fatigue and Quality of Life in Patients with Ulcerative Colitis in a Randomized Single-Blinded Placebo Controlled Study

PLoS ONE2016-03-0245 citations